8-KThe WireStrategic
Results of Operations
Filed May 7, 2026 · 1mo ago · Accession 0001193125-26-210283
Plain English
NewAmsterdam Pharma Company N.V. reported its first quarter financial results for the period ended March 31, 2026, and provided corporate updates. The company announced its cash position, revenue, research and development expenses, selling, general and administrative expenses, and net loss for the quarter.
Filing details
- Company
- NewAmsterdam Pharma Co N.V.
- Ticker
- NAMS
- CIK
- 1936258
- Form type
- 8-K
- Filing date
- May 7, 2026
- Report date
- May 7, 2026
- Document
- nams-20260507.htm
- Size
- 698 KB